In line with the in vitro data, RELA‐deficient HepG2‐WT cells did not exhibit an expansion advantage over control cells in xenografts (Figure S6D,E, Supporting Information), whereas RELA ablation enhanced tumor growth of HepG2‐TP53R249S in vivo (Figure S6D,E, Supporting Information). Here, RELA is linked to neoplasm.